Compare Sun Pharma with Lupin - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SUN PHARMA vs LUPIN - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    SUN PHARMA LUPIN SUN PHARMA/
LUPIN
 
P/E (TTM) x 30.8 42.4 72.7% View Chart
P/BV x 4.2 3.8 109.1% View Chart
Dividend Yield % 0.5 0.6 89.7%  

Financials

 SUN PHARMA   LUPIN
EQUITY SHARE DATA
    SUN PHARMA
Mar-20
LUPIN
Mar-21
SUN PHARMA/
LUPIN
5-Yr Chart
Click to enlarge
High Rs4841,122 43.2%   
Low Rs315576 54.8%   
Sales per share (Unadj.) Rs136.9334.2 40.9%  
Earnings per share (Unadj.) Rs17.427.0 64.5%  
Cash flow per share (Unadj.) Rs26.046.6 55.8%  
Dividends per share (Unadj.) Rs4.006.50 61.5%  
Dividend yield (eoy) %1.00.8 130.7%  
Book value per share (Unadj.) Rs188.7300.1 62.9%  
Shares outstanding (eoy) m2,399.34453.68 528.9%   
Bonus / Rights / Conversions ---  
Price / Sales ratio x2.92.5 115.0%   
Avg P/E ratio x22.931.4 73.0%  
P/CF ratio (eoy) x15.418.2 84.4%  
Price / Book Value ratio x2.12.8 74.9%  
Dividend payout %22.924.0 95.3%   
Avg Mkt Cap Rs m958,894385,072 249.0%   
No. of employees `000NANA-   
Total wages/salary Rs m63,62428,259 225.1%   
Avg. sales/employee Rs ThNMNM-  
Avg. wages/employee Rs ThNMNM-  
Avg. net profit/employee Rs ThNMNM-  
INCOME DATA
Net Sales Rs m328,375151,630 216.6%  
Other income Rs m6,5161,363 478.1%   
Total revenues Rs m334,891152,993 218.9%   
Gross profit Rs m67,13525,669 261.5%  
Depreciation Rs m20,5288,874 231.3%   
Interest Rs m3,0271,406 215.3%   
Profit before tax Rs m50,09616,751 299.1%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m8,2284,485 183.4%   
Profit after tax Rs m41,86812,266 341.3%  
Gross profit margin %20.416.9 120.8%  
Effective tax rate %16.426.8 61.3%   
Net profit margin %12.88.1 157.6%  
BALANCE SHEET DATA
Current assets Rs m316,542139,864 226.3%   
Current liabilities Rs m157,06484,361 186.2%   
Net working cap to sales %48.636.6 132.7%  
Current ratio x2.01.7 121.6%  
Inventory Days Days15869 229.0%  
Debtors Days Days105108 97.2%  
Net fixed assets Rs m334,23094,439 353.9%   
Share capital Rs m2,399907 264.4%   
"Free" reserves Rs m450,245135,229 333.0%   
Net worth Rs m452,645136,136 332.5%   
Long term debt Rs m20,289161 12,586.4%   
Total assets Rs m650,772234,302 277.7%  
Interest coverage x17.512.9 135.9%   
Debt to equity ratio x00 3,785.4%  
Sales to assets ratio x0.50.6 78.0%   
Return on assets %6.95.8 118.2%  
Return on equity %9.29.0 102.7%  
Return on capital %11.213.3 84.3%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m74,21951,027 145.4%   
Fx outflow Rs m27,96421,081 132.6%   
Net fx Rs m46,25529,946 154.5%   
CASH FLOW
From Operations Rs m65,54818,218 359.8%  
From Investments Rs m-25,888-12,396 208.8%  
From Financial Activity Rs m-57,151-18,853 303.1%  
Net Cashflow Rs m-13,857-13,031 106.3%  

Share Holding

Indian Promoters % 54.5 46.6 117.0%  
Foreign collaborators % 0.0 0.3 -  
Indian inst/Mut Fund % 33.5 40.7 82.3%  
FIIs % 11.5 18.6 61.8%  
ADR/GDR % 0.0 0.0 -  
Free float % 45.5 53.2 85.6%  
Shareholders   757,366 302,292 250.5%  
Pledged promoter(s) holding % 6.4 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare SUN PHARMA With:   AMRUTANJAN HEALTHCARE  ZANDU REALTY  ROOPA INDUSTRIES  BHARAT PARENTALS  VENUS REMEDIES  



Today's Market

Sensex Ends 123 Points Higher; Bharti Airtel and Eicher Motors Among Top Nifty Gainers(Closing)

Indian share markets witnessed volatile trading activity throughout the day today and ended higher.

Related Views on News

SUN PHARMA Announces Quarterly Results (3QFY21); Net Profit Up 87.4% (Quarterly Result Update)

Feb 1, 2021 | Updated on Feb 1, 2021

For the quarter ended December 2020, SUN PHARMA has posted a net profit of Rs 19 bn (up 87.4% YoY). Sales on the other hand came in at Rs 88 bn (up 8.4% YoY). Read on for a complete analysis of SUN PHARMA's quarterly results.

SUN PHARMA 2019-20 Annual Report Analysis (Annual Result Update)

Dec 11, 2020 | Updated on Dec 11, 2020

Here's an analysis of the annual report of SUN PHARMA for 2019-20. It includes a full income statement, balance sheet and cash flow analysis of SUN PHARMA. Also includes updates on the valuation of SUN PHARMA.

LUPIN 2019-20 Annual Report Analysis (Annual Result Update)

Dec 7, 2020 | Updated on Dec 7, 2020

Here's an analysis of the annual report of LUPIN for 2019-20. It includes a full income statement, balance sheet and cash flow analysis of LUPIN. Also includes updates on the valuation of LUPIN.

SUN PHARMA Announces Quarterly Results (2QFY21); Net Profit Up 66.9% (Quarterly Result Update)

Nov 6, 2020 | Updated on Nov 6, 2020

For the quarter ended September 2020, SUN PHARMA has posted a net profit of Rs 19 bn (up 66.9% YoY). Sales on the other hand came in at Rs 86 bn (up 5.3% YoY). Read on for a complete analysis of SUN PHARMA's quarterly results.

LUPIN Announces Quarterly Results (2QFY21); Net Profit Up 271.3% (Quarterly Result Update)

Nov 6, 2020 | Updated on Nov 6, 2020

For the quarter ended September 2020, LUPIN has posted a net profit of Rs 2 bn (up 271.3% YoY). Sales on the other hand came in at Rs 38 bn (down 12.0% YoY). Read on for a complete analysis of LUPIN's quarterly results.

More Views on News

Most Popular

These Stocks Are Ready to Zoom(Fast Profits Daily)

Aug 3, 2021

These stocks are the best from a traders point of view.

A Trading Hack to Multiply Profits(Fast Profits Daily)

Jul 23, 2021

Use this trading hack and get a big boost in your trading profits.

How to Pick Momentum Stocks(Fast Profits Daily)

Jul 26, 2021

Use my trading momentum strategy to increase your trading profits.

Devyani International IPO: Key Points to Consider(Views On News)

Jul 31, 2021

Its raining IPOs as 4 public issues open next week on the same day. Which one will you subscribe to?

A Rare Opportunity for Long-Term Investors Amid the Rout in China's Tech Stocks(Profit Hunter)

Jul 29, 2021

The epicentre of a tech-bubble led market crash in 2021 is closer than you think.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2021
Get our special report Multibagger Stocks Guide (2021 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

SUN PHARMA SHARE PRICE


Aug 5, 2021 (Close)

TRACK SUN PHARMA

  • Track your investment in SUN PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

SUN PHARMA 8-QTR ANALYSIS

COMPARE SUN PHARMA WITH

MARKET STATS